These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36240294)

  • 1. Mechano-covalent protection of coagulation factor VIII by von Willebrand factor.
    Butera D; Wang HJ; Woon HG; Zhao YC; Ju LA; Hogg PJ
    Blood Adv; 2023 May; 7(10):2117-2128. PubMed ID: 36240294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():679-691. PubMed ID: 37204745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor.
    Elsheikh E; Lavin M; Heck LA; Larkin N; Mullaney B; Doherty D; Kennedy M; Keenan C; Guest T; O'Mahony B; Fazavana J; Fallon PG; Preston RJS; Gormley J; Ryan K; O'Connell NM; Singleton E; Byrne M; McGowan M; Roche S; Doyle M; Crowley MP; O'Shea SI; Reipert BM; Johnsen JM; Pipe SW; Di Paola J; Turecek PL; O'Donnell JS;
    J Thromb Haemost; 2023 May; 21(5):1123-1134. PubMed ID: 36775768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyphosphate Activates von Willebrand Factor Interaction with Glycoprotein Ib in the Absence of Factor VIII In Vitro.
    Montilla M; Atienza-Navarro I; García-Cozar FJ; Castro C; Rodríguez-Martorell FJ; Ruiz FA
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
    Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
    J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
    Saenko EL; Scandella D
    J Biol Chem; 1997 Jul; 272(29):18007-14. PubMed ID: 9218428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
    Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
    J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant expression of mutations causing von Willebrand disease type Normandy: characterization of a combined defect of factor VIII binding and multimerization.
    Schneppenheim R; Lenk H; Obser T; Oldenburg J; Oyen F; Schneppenheim S; Schwaab R; Will K; Budde U
    Thromb Haemost; 2004 Jul; 92(1):36-41. PubMed ID: 15213842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII: A Dynamic Modulator of Hemostasis and Thrombosis in Trauma.
    Tanaka KA; Terada R; Butt AL; Mazzeffi MA; McNeil JS
    Anesth Analg; 2023 May; 136(5):894-904. PubMed ID: 37058725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of an N-terminal fragment of von Willebrand factor in complex with factor VIII.
    Yee A; Oleskie AN; Dosey AM; Kretz CA; Gildersleeve RD; Dutta S; Su M; Ginsburg D; Skiniotis G
    Blood; 2015 Aug; 126(8):939-42. PubMed ID: 26065653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative and quantitative analysis of von Willebrand factor contained in a very high-purity plasma-derived FVIII concentrate.
    Samor B; Michalski C; Brandin MP; Andre MH; Chtourou S; Tellier Z
    Vox Sang; 2012 Jul; 103(1):35-41. PubMed ID: 22239246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-Dependent Interactions of von Willebrand Factor with Factor VIII and Protease ADAMTS 13 Demonstrated at a Single Molecule Level by Atomic Force Microscopy.
    Bonazza K; Rottensteiner H; Schrenk G; Frank J; Allmaier G; Turecek PL; Scheiflinger F; Friedbacher G
    Anal Chem; 2015 Oct; 87(20):10299-305. PubMed ID: 26369694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated release of VWF and FVIII and the biologic implications.
    Haberichter SL; Shi Q; Montgomery RR
    Pediatr Blood Cancer; 2006 May; 46(5):547-53. PubMed ID: 16470522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the interaction between factor VIII and von Willebrand factor by electron microscopy and mass spectrometry.
    Chiu PL; Bou-Assaf GM; Chhabra ES; Chambers MG; Peters RT; Kulman JD; Walz T
    Blood; 2015 Aug; 126(8):935-8. PubMed ID: 26065652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The D' domain of von Willebrand factor requires the presence of the D3 domain for optimal factor VIII binding.
    Przeradzka MA; Meems H; van der Zwaan C; Ebberink EHTM; van den Biggelaar M; Mertens K; Meijer AB
    Biochem J; 2018 Sep; 475(17):2819-2830. PubMed ID: 30111575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FVIII-VWF dos-à-dos.
    Krishnaswamy S
    Blood; 2015 Aug; 126(8):923-4. PubMed ID: 26294711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010.
    Gringeri A; Ofosu FA; Grancha S; Oldenburg J; Ewing NP; Federici AB
    Haemophilia; 2012 May; 18(3):469-75. PubMed ID: 21943193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into blood coagulation factor VIII: Procoagulant complexes, membrane binding, and antibody inhibition.
    Childers KC; Peters SC; Spiegel PC
    J Thromb Haemost; 2022 Sep; 20(9):1957-1970. PubMed ID: 35722946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke.
    Samai A; Monlezun D; Shaban A; George A; Dowell L; Kruse-Jarres R; Schluter L; El Khoury R; Martin-Schild S
    Stroke; 2014 Sep; 45(9):2789-91. PubMed ID: 25028444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A.
    Nichols TC; Bellinger DA; Reddick RL; Smith SV; Koch GG; Davis K; Sigman J; Brinkhous KM; Griggs TR; Read MS
    Blood; 1993 May; 81(10):2644-51. PubMed ID: 8490173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.